Jane N. Wainaina, MD, FACP
Vice Chair for Quality, Associate Professor
- Froedtert Hospital
- Preoperative Evaluation and Testing - Froedtert Hospital
- Infectious Disease Clinic - Froedtert Hospital
- Infectious Disease
- Internal Medicine
- English, Swahili
New & Established Patients Call
- MD - Doctor of Medicine
- FACP-Fellow of the American College of Physicians
Dr. Wainaina’s clinical practice in perioperative medicine includes medical risk assessment, stratification and mitigation prior to surgery, as well as management of medical conditions after surgery with the goal of avoiding, or quickly correcting, any medical complications that may arise. This is always carried out in close partnership with patients’ surgeons, anesthesiologists and any other specialists whose expertise may be required. In addition, Dr. Wainaina also holds administrative responsibility for the Froedtert Hospital Pre-operative clinic as the medical director.
Within the division of infectious disease, Dr. Wainaina cares for patients with a wide range of infections that are difficult to treat, including HIV, bloodstream, post-surgical, orthopedic-device related and other bone and joint infections, among others. She applies a team-based approach that includes nurses, social workers, and an infectious disease pharmacist to provide care within the hospital and outside, ensuring that treatment arrangements are appropriate to each patient’s situation, effectively and safely delivered. She is also the medical director for the Froedtert Hospital Antimicrobial Stewardship program in which she works with a team of infectious disease pharmacists to optimize the outcomes of patients in the hospital by advising on and facilitating use of the most appropriate antibiotic according to individual patient diagnosis.
Training the next generation of medical providers is a priority for Dr. Wainaina. She is involved in teaching at all levels and has received the Outstanding Medical Student Teacher award multiple times.
(Verhagen NB, Koerber NK, Szabo A, Taylor B, Wainaina JN, Evans DB, Kothari AN, N3C Consortium.) Ann Surg Oncol. 2023 Mar;30(3):1305-1308 PMID: 36479662 PMCID: PMC9734328 SCOPUS ID: 2-s2.0-85143492422 12/09/2022
(Russell LA, Craig C, Flores EK, Wainaina JN, Keshock M, Kasten MJ, Hepner DL, Edwards AF, Urman RD, Mauck KF, Oprea AD.) Mayo Clin Proc. 2022 Aug;97(8):1551-1571 PMID: 35933139 08/07/2022
(Foolad F, Huang AM, Nguyen CT, Colyer L, Lim M, Grieger J, Li J, Revolinski S, Mack M, Gandhi T, Wainaina JN, Eschenauer G, Patel TS, Marshall VD, Nagel J.) J Antimicrob Chemother. 2018 May 01;73(5):1402-1407 PMID: 29462306 SCOPUS ID: 2-s2.0-85047020330 02/21/2018
(Jha P, Stromich J, Cohen M, Wainaina JN.) Case Rep Infect Dis. 2016;2016:3879406 PMID: 27579194 PMCID: PMC4992527 09/01/2016